HTAtlas
← Back to explore

CADTH Guidance for Reporting Real-World Evidence

Guidelinepeer-reviewed✓ Source-grounded

This guidance helps researchers and decision-makers clearly report real-world evidence—information gathered from sources outside traditional clinical trials, like patient records or insurance data—so it can be reliably used in health technology assessment and regulatory decisions in Canada.

At a glance

Use when

When preparing real-world evidence for submission to regulatory or HTA bodies in Canada.

Avoid when

When reporting standards are already mandated by other established frameworks incompatible with Canadian guidance.

Inputs

Real-world data and details of analytical methods used in generating real-world evidence.

Outputs

Standardized, transparent reports of real-world evidence suitable for regulatory and HTA review.

How it works

Developed through a collaboration between Health Canada and Canada's Drug Agency (formerly CADTH, now Canada's Drug Agency), this guidance standardizes the reporting of real-world evidence (RWE) to enhance transparency, reliability, and utility in regulatory and HTA decision-making. It addresses methodological decisions in RWE generation and aims to support consistent evaluation across jurisdictions.

HTA domains
Clinical Effectiveness, Costs & Economic Evaluation, Safety
Assumptions
Transparent reporting improves the credibility and usability of real-world evidence in health decision-making.
Strengths
Developed collaboratively by key Canadian health authorities; designed for integration into both regulatory and HTA processes; promotes consistency and trust in RWE.
Limitations
Currently specific to the Canadian context; may require adaptation for use in other jurisdictions.
Also known as
CADTH RWE Reporting Guidance, Canadian Guidance for Reporting Real-World Evidence

Questions this answers

References & sources

Similar by meaning

Beta record. Generated from the primary source via AI extraction and independent audit, pending final human review.